Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki N et al. Mechanosensitive properties of gastric vagal afferent fibers in the rat. 1999 J. Neurophysiol. pmid:10561400
Torras J et al. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. 1999 Kidney Int. pmid:10571788
Bratt T et al. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands. 1999 Biochim. Biophys. Acta pmid:10572948
Grutters JC et al. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. 1999 Eur. Respir. J. pmid:10573242
Tekgül H et al. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. 1999 J. Child Neurol. pmid:10573462
Olszanecki R and Chłopicki S Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia. 1999 J. Physiol. Pharmacol. pmid:10574473
Kuśnierz B and Naskalski JW [Mediators of the inflammatory response in the course of acute pancreatitis]. 1999 Prz. Lek. pmid:10575924
Grassi S et al. Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 1999 Neuroscience pmid:10579215
Quinn JV and Slotman GJ Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. 1999 Crit. Care Med. pmid:10579269
Goldfarb R Investigations into the polydeterminant nature of sepsis. 1999 Crit. Care Med. pmid:10579296
Mizuki M et al. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor. 1999 Life Sci. pmid:10579457
Shin BA et al. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis. 1999 J. Nat. Prod. pmid:10579872
Rodrigues CO et al. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi. 1999 Biochem. Biophys. Res. Commun. pmid:10581161
Wu R et al. Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome. 1999 J. Intern. Med. pmid:10583710
Hendrickson HS et al. Intramolecularly quenched BODIPY-labeled phospholipid analogs in phospholipase A(2) and platelet-activating factor acetylhydrolase assays and in vivo fluorescence imaging. 1999 Anal. Biochem. pmid:10585741
Byrum RS et al. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. 1999 J. Immunol. pmid:10586081
Kafoury RM et al. Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. 1999 Am. J. Respir. Crit. Care Med. pmid:10588609
Kitsiouli EI et al. Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates. 1999 J. Lipid Res. pmid:10588961
Burns AR et al. Analysis of tight junctions during neutrophil transendothelial migration. 2000 J. Cell. Sci. pmid:10591624
Arbabi S et al. Priming interleukin 8 production: role of platelet-activating factor and p38. 1999 Arch Surg pmid:10593333
Wechsung E and Houvenaghel A Influence of platelet activating factor on gastrointestinal electrical activity and some haematological and clinical parameters in the conscious miniature pig. 1999 J. Vet. Pharmacol. Ther. pmid:10597537
Bosch RJ et al. Effects of parathyroid hormone-related protein on human mesangial cells in culture. 1999 Am. J. Physiol. pmid:10600786
Hashimoto S et al. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. 2000 Clin. Exp. Allergy pmid:10606930
Sawai H et al. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. 1999 J. Biol. Chem. pmid:10608884
Thurston G et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. 1999 Science pmid:10617467
Sibelius U et al. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. 2000 Jan 4-11 Circulation pmid:10618308
Fukuda S et al. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. 2000 Circ. Res. pmid:10625314
Kim DD et al. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. 2000 Microvasc. Res. pmid:10625566
Kaul DK et al. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. 2000 Blood pmid:10627437
Franke B et al. Sequential regulation of the small GTPase Rap1 in human platelets. 2000 Mol. Cell. Biol. pmid:10629034
Haines DD et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. 2000 J. Cardiovasc. Pharmacol. pmid:10630731
Montrucchio G et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10634803
Atuma C et al. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell- and platelet-activating factor receptor-dependent pathway in rats. 1999 Scand. J. Gastroenterol. pmid:10636064
Keularts IM et al. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. 2000 J. Biol. Chem. pmid:10636873
Chlopicki S et al. Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung. 1999 J. Physiol. Pharmacol. pmid:10639006
Tong N et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. 2000 J. Immunol. pmid:10640747
Clavijo LC et al. Platelet-activating factor and bacteremia-induced pulmonary hypertension. 2000 J. Surg. Res. pmid:10644485
Owaki T et al. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10644608
Munir I et al. Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B. 1999 J. Reprod. Fertil. pmid:10645245
Michibayashi T Interaction between platelet-aggregating response and vasoconstrictive response to platelet activating factor. 1999 J Smooth Muscle Res pmid:10647808
Miike S et al. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. 2000 J. Leukoc. Biol. pmid:10648006
Dichmann S et al. Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. 2000 Blood pmid:10648411
Ibe BO et al. Platelet activating factor acetylhydrolase activity in lamb lungs is up-regulated in the immediate newborn period. 2000 Mol. Genet. Metab. pmid:10655157
Modschiedler K et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. 2000 Arch. Dermatol. Res. pmid:10664013
Grimminger F et al. PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10666110
Marshall LA et al. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation. 1999 Adv. Exp. Med. Biol. pmid:10667333
Kato K Modulation of long-term potentiation in the CA1 area of rat hippocampus by platelet-activating factor. 1999 Adv. Exp. Med. Biol. pmid:10667334
Goldman R et al. Lipid mediators stimulate reactive oxygen species formation in immortalized human keratinocytes. 1999 Adv. Exp. Med. Biol. pmid:10667361
Yu R et al. Studies on the callus cultures of Ginkgo biloba and its metabolites-ginkgolides. 1999 Chin. J. Biotechnol. pmid:10668135
Gelbard HA Neuroprotective strategies for HIV-1-associated neurologic disease. 1999 Ann. N. Y. Acad. Sci. pmid:10668436
Partrick DA et al. Maximal human neutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation. 2000 Arch Surg pmid:10668885
Cowling RT and Birnboim HC Expression of serum- and glucocorticoid-regulated kinase (sgk) mRNA is up-regulated by GM-CSF and other proinflammatory mediators in human granulocytes. 2000 J. Leukoc. Biol. pmid:10670586
Burgermeister E et al. Inhibition of cytosolic phospholipase A(2) attenuates activation of mitogen-activated protein kinases in human monocytic cells. 2000 Eur. J. Pharmacol. pmid:10675727
Fu Y and Hu YM Prophylactic effects of tetramethyl pyrazine on mice with endotoxemia and its relationship with platelet-activating factor. 1999 Zhongguo Yao Li Xue Bao pmid:10678147
Kimura I et al. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. 2000 Eur. Respir. J. pmid:10678641
Orozco AS et al. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. 2000 Infect. Immun. pmid:10678917
Ishihara Y et al. Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. 2000 Infect. Immun. pmid:10678975
Fujimura M et al. No involvement of lipid mediators in a guinea pig model of ultrasonically nebulized distilled water-induced bronchoconstriction. 2000 Prostaglandins Other Lipid Mediat. pmid:10680775
Sugano T et al. Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts. 2000 Biol. Reprod. pmid:10684793
Werr J et al. Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. 2000 Blood pmid:10688841
Bleeker WK et al. Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase. 2000 Blood pmid:10688848
Weintraub ST et al. Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride. 2000 J. Am. Soc. Mass Spectrom. pmid:10689672
Nilsson G et al. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. 2000 Immunology pmid:10692052
De Plaen IG et al. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. 2000 Br. J. Pharmacol. pmid:10694237
Emingil G et al. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A. 2000 J. Periodontol. pmid:10695938
Zouki C et al. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. 2000 FASEB J. pmid:10698973
Tremblay G BN 52021 decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. 1999 Mediators Inflamm. pmid:10704058
Hidi R et al. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. 2000 Eur. Respir. J. pmid:10706503
Henderson WR et al. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. 2000 J. Immunol. pmid:10706731
Fukuda Y et al. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models. 2000 Eur. J. Pharmacol. pmid:10708725
Neuberger Y et al. A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. 2000 FEBS Lett. pmid:10708753
Nikbakht-Sangari M et al. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. 2000 Immunol. Invest. pmid:10709843
Turner PJ et al. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10711351
Maruoka S et al. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. 2000 Am. J. Respir. Crit. Care Med. pmid:10712344
McClenahan DJ et al. Role of platelet-activating factor in alveolar septal injury associated with experimentally induced pneumonic pasteurellosis in calves. 2000 Am. J. Vet. Res. pmid:10714514
Yamakawa Y et al. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. 2000 Ann. Surg. pmid:10714632
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Lo EJ et al. Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. 1999 Neuroreport pmid:10716216
Chen C and Bazan NG Platelet-activating factor inhibits ionotropic GABA receptor activity in cultured hippocampal neurons. 1999 Neuroreport pmid:10716218
Chen LW et al. Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. 2000 Shock pmid:10718373
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Sun Z et al. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. 2000 Dig Surg pmid:10720833
Vallee RB et al. The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. 2000 Biochim. Biophys. Acta pmid:10722879
Wang WZ et al. Platelet-activating factor contributes to postischemic vasospasm. 2000 J. Surg. Res. pmid:10729242
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Iglesias-De La Cruz MC et al. Phenotypic modifications of human mesangial cells by extracellular matrix: the importance of matrix in the contractile response to reactive oxygen species. 2000 Mar-Apr Exp. Nephrol. pmid:10729749
Schmidt J et al. Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. 1999 Int. J. Pancreatol. pmid:10732294
Berthou C et al. Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. 2000 Blood pmid:10733503
Desplat V et al. Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. 2000 Cancer Lett. pmid:10737702
Boccellino M et al. Effect of platelet-activating factor receptor expression on CHO cell motility. 2000 J. Cell. Physiol. pmid:10737901
Hagi A et al. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor. 2000 J. Med. Invest. pmid:10740976
Tan XD et al. Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. 2000 Br. J. Pharmacol. pmid:10742310
Wiese A et al. Structure-dependent effects of glucose-containing analogs of platelet activating factor (PAF) on membrane integrity. 2000 Biol. Chem. pmid:10746745
Howard KM and Olson MS The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. 2000 J. Biol. Chem. pmid:10748027
Ruchaud-Sparagano MH et al. Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. 2000 J. Biol. Chem. pmid:10748085
Ibe BO et al. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10749711
Koyama S et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10749742
Martin-Chouly CA et al. Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. 2000 Prostaglandins Other Lipid Mediat. pmid:10751643
Vincent JL et al. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. 2000 Crit. Care Med. pmid:10752807
Lendvai N et al. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. 2000 J. Immunol. pmid:10754337